Sensei Biotherapeutics
An innovator in the field of next-generation cancer immunotherapies.
Launch date
Employees
Market cap
€11.4m
Enterprise valuation
(€32m) (Public information from Sep 2024)
Share price
$0.49 SNSE
Gaithersburg Maryland (HQ)
Financials
Estimates*
USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
EBITDA | (18.0m) | (36.0m) | (50.2m) | (32.3m) | (33.9m) | (40.1m) | (47.5m) |
Profit | (20.1m) | (36.8m) | (48.6m) | (34.1m) | (31.4m) | (37.0m) | (43.5m) |
EV / EBITDA | - | -0.9x | 1.1x | -0.5x | -0.5x | -0.4x | -0.3x |
R&D budget | 11.2m | 21.7m | 30.4m | 18.3m | - | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$28.5m | Series A | ||
$30.0m | Series B | ||
N/A | $133m | IPO | |
Total Funding | €53.2m |
Related Content
Recent News about Sensei Biotherapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.